| RWICX | SRIGX | RWICX / SRIGX | |
| Total Expense Ratio | 1.06 | 0.90 | 118% |
| Annual Report Gross Expense Ratio | 1.06 | 2.24 | 47% |
| Fund Existence | 24 years | 19 years | - |
| Gain YTD | 13.814 | 9.242 | 149% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 158B | 22M | 718,182% |
| Annual Yield % from dividends | 1.09 | 1.24 | 88% |
| Returns for 1 year | 15.18 | 6.73 | 225% |
| Returns for 3 years | 42.71 | 17.21 | 248% |
| Returns for 5 years | 31.44 | -6.53 | -481% |
| Returns for 10 years | 91.15 | 3.40 | 2,682% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MVISX | 61.04 | 0.91 | +1.51% |
| Patient Opportunity IS | |||
| STCAX | 18.17 | 0.25 | +1.40% |
| Virtus Silvant Large-Cap Growth Stk I | |||
| AISHX | 5.73 | 0.03 | +0.53% |
| Aristotle Small/Mid Cap Equity C | |||
| HFQRX | 8.32 | N/A | N/A |
| Janus Henderson Global Equity Income N | |||
| STMSX | 27.50 | -0.04 | -0.15% |
| SEI Tax-Managed Small/Mid Cap F (SIMT) | |||